spacer
home > ict > autumn 2017 > spotlight
PUBLICATIONS
International Clinical Trials

Spotlight

In our efforts to constantly innovate the way in which
development teams see and analyse their trial data,
eClinical Solutions noticed that, for many biopharmaceutical
organisations, the process of data analytics and mapping
required a significant allocation of valuable time
and resources. With complex study designs, multiple
information sources, diverse datasets and frequent protocol
amendments, the world of clinical development has clearly
become a little convoluted. All these intricacies have made
it more difficult for firms to visibly analyse their study data
and has decreased the speed of FDA submissions.

However, eClinical Solutions has created a platform
that can make all of those complications a thing of the
past.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
eClinical Solutions
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nanobiotix announces that Bpifrance has awarded the company an interest free loan


More info >>

White Papers

High Containment FIBCs Offer a Safe and Cost Effective Alternative to their Rigid Counterparts

ILC Dover

As the need for powder containment and manufacturing in accordance with cGMP standards has grown over the years, companies have sought new alternatives to rigid IBCs. Recently high containment Flexible Intermediate Bulk Containers (FIBCs) have emerged which offer an alternative that provides both powder containment and the benefits of shipping with flexibles.
More info >>

 
Industry Events

7th annual Orphan Drugs and Rare Diseases UK

18-19 October 2017, Holiday Inn Kensington Forum, London

SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th & 19th October 2017 in Central London, UK. This year’s theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement